Several cancer types, such as thymoma (THYM), pancreatic adenocarcinoma (PAAD), and lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), are characterized by dysregulated expression of another anti-ferroptotic factor, FSP1 (Suppl. Here, AIFM2 is linked to diffuse large B-cell lymphoma.